Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Brandes Investment Partners, L.P. filed an amended Schedule 13G reporting a significant passive ownership position in Utah Medical Products Inc. Brandes is deemed the beneficial owner of 475,158 common shares, representing 14.92% of the outstanding class, held across mutual funds and other accounts it advises. Brandes reports shared voting power over 435,111 shares and shared dispositive power over 475,158 shares, with no sole voting or dispositive power. 218,681 shares, or 6.87% of the class, are held in the Brandes Small Cap Value Fund, a series of Datum One Series Trust. Brandes states that the filing does not constitute an admission that the reporting persons form a group.
Key Figures
Beneficial ownership:475,158 sharesPercent of class:14.92%Shared voting power:435,111 shares+3 more
6 metrics
Beneficial ownership475,158 sharesCommon shares of Utah Medical Products beneficially owned by Brandes
Percent of class14.92%Portion of Utah Medical Products common stock attributed to Brandes
Shared voting power435,111 sharesShares for which Brandes reports shared power to vote or direct the vote
Shared dispositive power475,158 sharesShares for which Brandes reports shared power to dispose or direct disposition
Brandes Small Cap Value Fund holdings218,681 sharesUtah Medical Products shares held by Brandes Small Cap Value Fund
Fund interest in class6.87%Portion of Utah Medical Products common stock held via Brandes Small Cap Value Fund
"may be deemed to be the beneficial owner of the shares of the Issuer"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
shared voting powerfinancial
"Shared Voting Power 435,111.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerfinancial
"Shared Dispositive Power 475,158.00"
Schedule 13Gregulatory
"Brandes has filed this joint 13G on behalf of Brandes and the Fund"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Investment Company Act of 1940regulatory
"mutual funds registered under the Investment Company Act of 1940"
A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.
beneficiaries of employee benefit planfinancial
"beneficiaries of employee benefit plan, pension fund or endowment fund"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Utah Medical Products (UTMD) is owned by Brandes Investment Partners?
Brandes Investment Partners reports beneficial ownership of 475,158 Utah Medical Products shares, representing 14.92% of the outstanding common stock. This ownership is held across mutual funds and other accounts for which Brandes acts as investment adviser or sub-adviser.
How many Utah Medical Products (UTMD) shares does the Brandes Small Cap Value Fund hold?
The Brandes Small Cap Value Fund holds 218,681 Utah Medical Products shares, a series of Datum One Series Trust. Brandes states this represents an interest of 6.87% of the company’s common stock attributable to that fund’s holdings alone.
What voting and dispositive powers does Brandes report over Utah Medical Products (UTMD) shares?
Brandes reports shared voting power over 435,111 shares and shared dispositive power over 475,158 shares of Utah Medical Products. It reports no sole voting or sole dispositive power over any of the shares in this Schedule 13G/A filing.
Is Brandes Investment Partners filing as part of a group in this Utah Medical Products (UTMD) 13G/A?
Brandes states that it filed a joint Schedule 13G on behalf of itself and the Brandes Small Cap Value Fund under Rule 13d-1(k). It explicitly notes that nothing in the statement is an admission that the reporting persons constitute a group.
Who ultimately benefits from the Utah Medical Products (UTMD) shares managed by Brandes?
Brandes explains that fund shareholders and other account beneficiaries have the economic interest in the Utah Medical Products shares it manages. The Brandes Small Cap Value Fund has the right to receive dividends or sale proceeds on its 6.87% stake in the company.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 4)
UTAH MEDICAL PRODUCTS INC
(Name of Issuer)
Common Shares
(Title of Class of Securities)
917488108
(CUSIP Number)
06/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
917488108
1
Names of Reporting Persons
BRANDES INVESTMENT PARTNERS, LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
435,111.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
475,158.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
475,158.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
14.9 %
12
Type of Reporting Person (See Instructions)
IA, PN
SCHEDULE 13G
CUSIP Number(s):
917488108
1
Names of Reporting Persons
Datum One Series Trust
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
MASSACHUSETTS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
218,681.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
218,681.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
218,681.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.9 %
12
Type of Reporting Person (See Instructions)
IV
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
UTAH MEDICAL PRODUCTS INC
(b)
Address of issuer's principal executive offices:
7043 S 300 WEST, MIDVALE, UTAH, 84047-1048.
Item 2.
(a)
Name of person filing:
Brandes Investment Partners, L.P.
(b)
Address or principal business office or, if none, residence:
4275 Executive Square, 5th Floor, La Jolla, CA 92037
(c)
Citizenship:
Delaware
(d)
Title of class of securities:
Common Shares
(e)
CUSIP No.:
917488108
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
449,680
Note 1: Brandes Investment Partners, LP, (Brandes) an investment adviser registered under Section 203 of the Investment Advisors Act of 1940, furnishes investment advice to mutual funds registered under the Investment Company Act of 1940 (Funds). Each Fund is a series of the Datum One Series Trust. Brandes also serves as investment adviser or sub-adviser to certain other commingled funds and separate accounts (Accounts) and may be deemed to be the beneficial owner of the shares of the Issuer held by the Accounts and Funds. 218,681 of the 475,158 shares beneficially owned by Brandes are held in Brandes Small Cap Value Fund, a series of Datum One Series Trust. Brandes has filed this joint 13G on behalf of Brandes and the Fund, pursuant to Rule 13d-1(k). Neither the filing of this statement nor anything herein shall be construed as an admission that the reporting persons constitute a group.
(b)
Percent of class:
14.92 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
435,111
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
475,158
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
The Fund described in Note 1 above has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the securities held in their respective accounts. To the knowledge of Brandes, the interest of the Fund amounts to 6.87% of the class of securities.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
